Q3 2022 Holdings
Filed 2022-11-14 | 116 holdings | $543.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $154.0M | 5,472,033 | 28.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $104.5M | 5,321,032 | 19.2% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $60.6M | 11,350,085 | 11.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $47.9M | 3,207,441 | 8.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $28.5M | 336,481 | 5.2% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $26.6M | 10,933,387 | 4.9% |
| Cytek Biosciences Inc(CTKB) | COM | 23285D109 | $19.0M | 1,289,534 | 3.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $17.4M | 666,477 | 3.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $16.9M | 1,697,033 | 3.1% |
| Artivion Inc(AORT) | COM | 228903100 | $16.7M | 1,204,229 | 3.1% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $16.0M | 1,667,123 | 2.9% |
| Axogen Inc(AXGN) | COM | 05463X106 | $11.3M | 949,626 | 2.1% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $6.7M | 766,231 | 1.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.4M | 341,239 | 1.0% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $4.0M | 400,000 | 0.7% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.8M | 894,346 | 0.5% |
| Clover Health Investments Co(CLOV) | COM CL A | 18914F103 | $2.6M | 1,500,000 | 0.5% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $285.8K | 27,372,917 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $194.5K | 2,784,796 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $184.0K | 6,511,727 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $158.1K | 2,322,247 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $115.1K | 57,558,451 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $108.5K | 3,306,649 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $108.2K | 10,247,073 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $99.0K | 3,470,563 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $98.2K | 10,248,624 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $88.2K | 2,383,478 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $86.7K | 1,468,512 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $76.6K | 2,122,535 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $58.6K | 6,963,277 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $51.8K | 2,887,860 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $51.6K | 5,047,264 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $46.3K | 2,465,405 | 0.0% |
| Travere Therapeutics Inc | NOTE 2.250% 3/0 | 89422GAA5 | $46.0K | $45,000,000 | 0.0% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $45.8K | 9,146,730 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $45.7K | 2,360,139 | 0.0% |
| Veru Inc(VERUEUR) | COM | 92536C103 | $44.8K | 3,893,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $43.5K | 1,943,097 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $43.3K | 316,544 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $41.2K | 1,713,134 | 0.0% |
| VBI Vaccines Inc CDA(VAC2USD) | COM NEW | 91822J103 | $37.2K | 52,335,002 | 0.0% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $35.4K | 1,601,979 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $32.2K | 1,655,007 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $31.6K | 578,253 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $28.0K | 253,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $27.3K | 330,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $27.1K | 4,400,099 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $25.0K | 1,220,575 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $25.0K | 366,400 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $25.0K | 2,500,000 | 0.0% |